TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: <0.100nMAssay Description:Binding affinity to HIV-1 protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 0.5nMAssay Description:Compound was assayed for inhibition against HIV protease activityMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 0.600nMAssay Description:Compound was assayed for inhibition against HIV protease activityMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 7nMAssay Description:Binding affinity to HIV-1 protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 15nMAssay Description:Compound was assayed for inhibition against HIV protease activityMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 15nMAssay Description:Binding affinity to HIV-1 protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 17nMAssay Description:Compound was assayed for inhibition against HIV protease activityMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 17nMAssay Description:Binding affinity to HIV-1 protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 17nMAssay Description:Compound was assayed for inhibition against HIV protease activityMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 20nMAssay Description:Binding affinity to HIV-1 protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 20nMAssay Description:Binding affinity to HIV-1 protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 22nMAssay Description:Binding affinity of the compound against HIV-1 protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 27nMAssay Description:Binding affinity to HIV-1 protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 29nMAssay Description:Binding affinity to HIV-1 protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 38nMAssay Description:Binding affinity to HIV-1 protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 38nMAssay Description:Binding affinity to HIV-1 protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 40nMAssay Description:Binding affinity to HIV-1 protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 43nMAssay Description:Binding affinity of the compound against HIV-1 protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 50nMAssay Description:Binding affinity to HIV-1 protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 65nMAssay Description:Binding affinity to HIV-1 protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 66nMAssay Description:Binding affinity to HIV-1 protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 76nMAssay Description:Binding affinity to HIV-1 protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 104nMAssay Description:Binding affinity to HIV-1 protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 125nMAssay Description:Binding affinity to HIV-1 protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 173nMAssay Description:Binding affinity to HIV-1 protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 200nMAssay Description:Binding affinity to HIV-1 protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 220nMAssay Description:Binding affinity to HIV-1 protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 300nMAssay Description:Binding affinity to HIV-1 protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 600nMAssay Description:Binding affinity to HIV-1 protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 680nMAssay Description:Binding affinity to HIV-1 protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 1.00E+3nMAssay Description:Compound was assayed for inhibition against HIV protease activityMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 1.40E+3nMAssay Description:Binding affinity to HIV-1 protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 1.50E+3nMAssay Description:Compound was assayed for inhibition against HIV protease activityMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 2.10E+3nMAssay Description:Binding affinity of the compound against HIV-1 protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 3.00E+3nMAssay Description:Compound was assayed for inhibition against HIV protease activityMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 3.40E+3nMAssay Description:Binding affinity of the compound against HIV-1 protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: >1.00E+4nMAssay Description:Binding affinity of the compound against HIV-1 protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: >1.00E+4nMAssay Description:Binding affinity of the compound against HIV-1 protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: >1.00E+4nMAssay Description:Binding affinity of the compound against HIV-1 protease was determinedMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Vertex Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: >2.00E+4nMAssay Description:Binding affinity of the compound against HIV-1 protease was determinedMore data for this Ligand-Target Pair
Affinity DataIC50: 0.600nMpH: 7.5 T: 2°CAssay Description:The assay involves the phosphorylation of a biotinylated substrate and the detection of this phosphorylation after the addition of a streptavidin-all...More data for this Ligand-Target Pair
Affinity DataIC50: 1nMpH: 7.5 T: 2°CAssay Description:The assay involves the phosphorylation of a biotinylated substrate and the detection of this phosphorylation after the addition of a streptavidin-all...More data for this Ligand-Target Pair
Affinity DataIC50: 1nMAssay Description:The assay involves the phosphorylation of a biotinylated substrate and the detection of this phosphorylation after the addition of a streptavidin-all...More data for this Ligand-Target Pair
Affinity DataIC50: 1nMAssay Description:The assay involves the phosphorylation of a biotinylated substrate and the detection of this phosphorylation after the addition of a streptavidin-all...More data for this Ligand-Target Pair
Affinity DataIC50: 1nMAssay Description:The assay involves the phosphorylation of a biotinylated substrate and the detection of this phosphorylation after the addition of a streptavidin-all...More data for this Ligand-Target Pair
Affinity DataIC50: 1nMAssay Description:The assay involves the phosphorylation of a biotinylated substrate and the detection of this phosphorylation after the addition of a streptavidin-all...More data for this Ligand-Target Pair
Affinity DataIC50: 1nMpH: 7.5 T: 2°CAssay Description:The assay involves the phosphorylation of a biotinylated substrate and the detection of this phosphorylation after the addition of a streptavidin-all...More data for this Ligand-Target Pair
Affinity DataIC50: 1nMpH: 7.5 T: 2°CAssay Description:The assay involves the phosphorylation of a biotinylated substrate and the detection of this phosphorylation after the addition of a streptavidin-all...More data for this Ligand-Target Pair
Affinity DataIC50: 1nMpH: 7.5 T: 2°CAssay Description:The assay involves the phosphorylation of a biotinylated substrate and the detection of this phosphorylation after the addition of a streptavidin-all...More data for this Ligand-Target Pair
Affinity DataIC50: 1nMpH: 7.5 T: 2°CAssay Description:The assay involves the phosphorylation of a biotinylated substrate and the detection of this phosphorylation after the addition of a streptavidin-all...More data for this Ligand-Target Pair